Amphadase Amphastar Pharmaceuticals, Inc - Treatment for Adjunctive Agent
Amphadase (formulated as a replacement for Wydase which was
discontinued in 2001) contains hyaluronidase, an enzyme that breaks
down hyaluronic acid in connective tissue, increasing tissue
permeability. Hyaluronidase is typically used as an adjunctive
agent to facilitate the dispersion and absorption of other drugs.
Posted: October 2004
Amphadase (hyaluronidase) FDA Approval History